108
Participants
Start Date
September 6, 2024
Primary Completion Date
August 30, 2026
Study Completion Date
August 30, 2026
Pregnenolone
Pregnenolone 250 mg BID x 14 DAYS, followed by Pregnenolone 500 mg BID x 14 DAYS, followed by Pregnenolone 1000 mg BID x thereafter for the remainder of the 8-week trial
Placebo
Same as active comparator, except placebo dispensed.
NOT_YET_RECRUITING
Duke University School of Medicine, Durham
RECRUITING
Durham VA Health Care System, Durham
Christine Marx, MD
OTHER